STOCK TITAN

Autonomix CFO granted 15,000 restricted shares

Autonomix Medical’s CFO received a 15,000-share restricted stock award that vests in one year, increasing his direct holdings to 15,119 shares.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Autonomix Medical, Inc. (symbol: AMIX) is the issuer of record for a Form 4 filing submitted to the SEC. Smith Trent N. reported acquisition or exercise transactions in this Form 4 filing.

Autonomix Medical, Inc. (AMIX) reported that its chief financial officer, Trent N. Smith, received a grant of 15,000 shares of common stock on September 3, 2026 as a restricted stock award that vests one year from that date. Following this equity award, he directly holds 15,119 shares of Autonomix Medical common stock. No Rule 10b5-1 trading plan is reported for this transaction.

Positive

  • None.

Negative

  • None.
Insider Smith Trent N.
Role CFO
Type Security Shares Price Value
Grant/Award Common Stock F1 15,000 -- --
Holdings After Transaction: Common Stock — 15,119 shares (Direct)
Footnotes (1)
  1. F1. Represents restricted stock award vesting one-year from the date of issuance of September 3, 2026.
Shares granted 15,000 shares Restricted stock award to CFO on September 3, 2026
Shares owned after transaction 15,119 shares Direct common stock holdings of CFO after the grant
Vesting period 1 year Restricted stock award vests one year from September 3, 2026
restricted stock award financial
"Represents restricted stock award vesting one-year from the date of issuance"
A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.
vesting financial
"restricted stock award vesting one-year from the date of issuance"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
direct ownership financial
"total shares following transaction are held with direct ownership"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AMIX report for its CFO on September 3, 2026?

Autonomix Medical (AMIX) reported that CFO Trent N. Smith received a grant of 15,000 shares of common stock on September 3, 2026 as a restricted stock award vesting one year from that date.

How many AMIX shares does the CFO own after this Form 4 transaction?

After the reported grant, CFO Trent N. Smith directly holds 15,119 shares of Autonomix Medical, Inc. common stock, according to the filing’s post-transaction ownership figure.

Was the AMIX CFO’s September 3, 2026 equity grant a purchase or a compensation award?

The filing describes the transaction as a grant or award acquisition of 15,000 shares of common stock, characterized as a restricted stock award rather than an open-market purchase.

When do the AMIX CFO’s 15,000 restricted shares vest?

The 15,000-share restricted stock award granted to Autonomix Medical’s CFO vests one year from the date of issuance of September 3, 2026, according to the footnote in the Form 4.

Was the AMIX CFO’s Form 4 transaction under a Rule 10b5-1 plan?

No. The Form 4 indicates that the Rule 10b5-1 checkbox is not affirmed, and there is no footnote stating the transaction was made pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Smith Trent N.

(Last)(First)(Middle)
21 WATERWAY AVENUE
SUITE 300

(Street)
THE WOODLANDS TEXAS 77380

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Autonomix Medical, Inc. [ AMIX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CFO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/03/2026A15,000A(1)15,119D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents restricted stock award vesting one-year from the date of issuance of September 3, 2026.
/s/ Trent Smith09/21/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading